Evaluating Evotec's Valuation After Recent Share Price Surge: Undervalued or Optimistic?
ByAinvest
Tuesday, Oct 28, 2025 7:28 pm ET1min read
EVO--
Evotec (XTRA:EVT) shares have surged 19% in the past month, following a rocky first half of the year. Despite this, the 1-year total shareholder return remains negative, and the three- and five-year returns are underwater. Analysts see significant upside from current levels, but the question remains whether Evotec is undervalued or if all future growth is already reflected in the price. The most popular narrative places fair value at €9.47, a premium to the last close of €7.07, while the SWS DCF model estimates a fair value of €35.72, far above the current share price and consensus narrative.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet